Innoviva Inc (NQ: INVA )

11.43 USD -0.19 (-1.64%)

Official Closing Price Updated: 4:22 PM EST, Feb 26, 2021 Add to My Watchlist

Price and Volume

Volume	677,000
Open	11.66
Bid (Size)	11.26 (4)
Ask (Size)	13.00 (6)
Prev. Close	11.62
Today's Range	11.42 - 11.78
52wk Range	7.580 - 15.62
Shares Outstanding	101,470,190
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Armata Pharmaceuticals Announces $20 Million Investment to Support Advancement of the Company's Bacteriophage Development Programs

January 27, 2021

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and...

Innoviva Reports Fourth Quarter 2020 Financial Results

February 03, 2021

Innoviva, Inc. (NASDAQ: INVA) (the Company) today reported financial results for the fourth quarter ended December 31, 2020.

Performance

YTD	-8.41%	-8.41%
1 Month	-4.83%	-4.83%
3 Month	+9.33%	+9.33%
6 Month	-2.39%	-2.39%
1 Year	-17.05%	-17.05%

More News

A Look Into Healthcare Sector Value Stocks

February 15, 2021

Innoviva: Q4 Earnings Insights

February 03, 2021

Innoviva Reports Third Quarter 2020 Financial Results

October 28, 2020

Notable Insider Buys Seen In The Past Week: Green Brick, Intel, Teledyne And More

January 30, 2021

First Week of September 17th Options Trading For Innoviva (INVA)

January 22, 2021

5 Value Stocks To Watch In The Healthcare Sector

January 11, 2021

5 Value Stocks In The Healthcare Sector

January 04, 2021

FDA Approves Trelegy Ellipta as the First Once-Daily Single Inhaler Triple Therapy for the Treatment of Both Asthma and COPD in the US

September 09, 2020

First Week of INVA February 2021 Options Trading

December 21, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.